Petredis Investment Advisors LLC Abbott Laboratories Transaction History
Petredis Investment Advisors LLC
- $957 Billion
- Q1 2025
A detailed history of Petredis Investment Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Petredis Investment Advisors LLC holds 37,460 shares of ABT stock, worth $4.98 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
37,460
Previous 36,830
1.71%
Holding current value
$4.98 Million
Previous $4.17 Billion
19.28%
% of portfolio
0.52%
Previous 0.43%
Shares
15 transactions
Others Institutions Holding ABT
# of Institutions
3,545Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$22.6 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.3 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.89 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.75 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $233B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...